“Your source for timely information on under-followed emerging growth companies”
Daily Notes:
2/24/2015
Top Story:
Pre-Clinical Animal Pilot Study Shows Arch Therapeutics’ AC5(TM) Compared Favorably Versus a Popular...
Pre-Clinical Animal Pilot Study Shows Arch Therapeutics" AC5(TM) Compared Favorably Versus a Popular Hemostatic Agent
Tuesday, February 24, 2015
Pre-Clinical Animal Pilot Study Shows Arch Therapeutics" AC5(TM) Compared Favorably Versus a Popular Hemostatic Agent
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment